Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
TuHURA Biosciences secures $1.5M draw from revolving credit facility
PRIVATESep 02, 2026•6 days ago
Amount Raised
$1.5 Million
Round Type
Debt Financing
TampaBiotechnologyHealth CareTherapeutics
Investors
Parkview Holdings One Llc
Description
On September 2, 2026, TuHURA Biosciences, Inc. borrowed an additional $1.5 million under its revolving credit facility with Parkview Holdings One LLC. The funds are expected to be utilized for general corporate purposes. This draw is part of a broader Loan Agreement that allows for a maximum of $50 million.
Company Information
Company
TuHURA Biosciences
Location
10500 University Center Drive
Tampa, Florida, United States
About
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.
Don't miss TuHURA Biosciences's next move
Get an email the moment TuHURA Biosciences raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
3 contacts
Verified contactsIan F., Senior Research Scientist hidden
Predictive Intelligence
Strategic
ML-powered predictions for TuHURA Biosciences's next move
TampaBiotechnologyHealth CareTherapeutics